By Rory McCann, Marketing Manager & Conference Producer, LSN
Antoine Prestat and Michele Marzola met at Digital RESI March and spent the past several months building up a strategic partnership that will help launch French biotech, PEP-Therapy into clinical trials this summer.
In Part II of our two-part interview about Michele and Antoine’s strategic partnership, we discuss how PEP-Therapy stood out at RESI, and how Antoine worked with investors for a strong Series A raise.
Check out Part I of our interview and if you’re looking to get in front of qualified investors at Digital RESI June, there’s still time to sign up!
Leave a Reply